Telomere length is an independent prognostic marker in MDS but not in de novo AML
Jenna Williams; Nicole H. Heppel; Bethan Britt‐Compton; Julia W. Grimstead; Rhiannon E. Jones; Sudhir Tauro; David T. Bowen; Steven Knapper; Michael Groves; Robert K. Hills; Chris Pepper; Duncan M. Baird; Chris Fegan
Author Information: Division of Cancer and Genetics
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.